AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18507661
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin alone (placebo)
Trial: 7561530
Drug: Anti-TB chemotherapy
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TB chemotherapy with rifampicin (isoniazid, pyrazinamide, ethambutol, and rifampicin)
Trial: 7561530
Drug: Anti-TB chemotherapy
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TB chemotherapy without rifampicin (isoniazid, pyrazinamide, and ethambutol)
Trial: 7561530
Drug: Anti-TB chemotherapy
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TB chemotherapy with rifampicin
Trial: 7561530
Drug: Anti-TB chemotherapy
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TB chemotherapy without rifampicin
Trial: 1766577
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of reduced GSH for 30 days
Trial: 1766577
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of vitamin K for 30 days
Trial: 7184670
Drug: Chlorpropamide tablet
RxNorm normalized name: Chlorpropamide Tablets
DrugBank: Chlorpropamide (DB00672)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpropamide tablet (250 mg)
Trial: 760732
Drug: Chlorpropamide suspension
RxNorm normalized name: Chlorpropamide
DrugBank: Chlorpropamide (DB00672)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpropamide suspension
Trial: 19678780
Drug: C. domestica
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C. domestica extracts 2 g per day for 6 weeks
Trial: 19678780
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg per day for 6 weeks
Trial: 15895286
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 1 mg/day p.o. for 3 months
Trial: 12572869
Drug: Germinated barley
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Germinated barley foodstuff (GBF) 20-30 g daily for 4 weeks
Trial: 12572869
Drug: Baseline anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline anti-inflammatory therapy for 4 weeks
Trial: 9734472
Drug: Arachidonic acid
RxNorm normalized name: Arachidonic acid
DrugBank: Arachidonic Acid (DB04557)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arachidonic acid (AA) at doses of 10(-10) to 10(-5) mol/L
Trial: 9734472
Drug: 17-octadecynoic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17-octadecynoic acid (17-ODYA) at 10(-5) mol/L (P450 inhibitor)
Trial: 9734472
Drug: Indomethacin (INDO)
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin (INDO) at 10(-5) mol/L (cyclooxygenase inhibitor)
Trial: 9734472
Drug: N omega-nitro-L-arginine
RxNorm normalized name: .alpha.N-(methoxycarbonyl)-L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N omega-nitro-L-arginine methyl ester (L-NAME) at 10(-4) mol/L (NO synthase inhibitor)
Trial: 9734472
Drug: Miconazole at
RxNorm normalized name: Miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole at 10(-5) mol/L (P450 inhibitor)
Trial: 9734472
Drug: 40 mmol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mmol/L KCl
Trial: 9734472
Drug: Charybdotoxin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Charybdotoxin at 10(-8) mol/L (large-conductance Ca2+-activated K+ channel blocker)
Trial: 1894852
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg bite-and-swallow) after calcium infusion (10 ml of 10% calcium chloride in 50 ml of 5% dextrose in water)
Trial: 1894852
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg bite-and-swallow) after placebo infusion (5% dextrose in water)
Trial: 1894852
Drug: Calcium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium infusion (10 ml of 10% calcium chloride in 50 ml of 5% dextrose in water)
Trial: 1894852
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion (5% dextrose in water)
Trial: 1894852
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg bite-and-swallow) after calcium infusion
Trial: 30714984
Drug: Vestibular rehabilitation
RxNorm normalized name: Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein (GP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vestibular rehabilitation therapy (VRT) (n = 20)
Trial: 30714984
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of corticosteroids and vestibular rehabilitation (n = 20)
Trial: 24427649
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg IV at induction of anesthesia)
Trial: 21635675
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg prednisone
Trial: 14605050
Drug: Linezolid, 600
RxNorm normalized name: Linezolid, 600 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid, 600 mg, q12h for 7 to 21 days
Trial: 14605050
Drug: Vancomycin, 1
RxNorm normalized name: Vancomycin, 100 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin, 1 g, q12h for 7 to 21 days
Trial: 8632551
Drug: Self-injection
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-injection
Trial: 30312159
Drug: Manualized Swedish
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manualized Swedish massage therapy (SMT)
Trial: 22196125
Drug: Early aquatic
RxNorm normalized name: Mentha aquatica leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early aquatic therapy (after 6 days)
Trial: 22196125
Drug: Late aquatic
RxNorm normalized name: Mentha aquatica leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late aquatic therapy (after 14 days)
Trial: 21048810
Drug: Silymarin and
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin and selenium (SM-Se) combination (570 mg of silymarin and 240 µg of selenium as selenomethionine)
Trial: 16955461
Drug: HCV antibody
RxNorm normalized name: HCV-086
DrugBank: HCV-086 (DB05884)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCV antibody detection immunoassay
Trial: 9821996
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide administered to patients receiving norepinephrine
Trial: 9821996
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide administered to patients not receiving norepinephrine
Trial: 9051541
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg/kg (Group MH)
Trial: 9051541
Drug: Midazolam 0.035
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.035 mg/kg (Group ML)
Trial: 1276560
Drug: Medicine group
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine group (antidepressive drug treatment)
Trial: 1276560
Drug: Natural Process
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural Process group (no treatment)
Trial: 21421014
Drug: GLP‐2, 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐2, 1600 μg subcutaneously (SC)
Trial: 19333166
Drug: Tramadol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (50 mg, 3 times daily)
Trial: 19333166
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 tablet, 3 times daily)
Trial: 16943675
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy with standardized latex extract
Trial: 9230243
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg twice daily for 6 months
Trial: 3318371
Drug: DPI 201-106
RxNorm normalized name: treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: DPI 201-106 (80 mg and 100 mg)
Trial: 20386077
Drug: darunavir/ritonavir 900/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: darunavir/ritonavir 900/100 mg once daily
Trial: 20386077
Drug: darunavir/ritonavir 600/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: darunavir/ritonavir 600/100 mg twice daily
Trial: 7569093
Drug: Iopentol 300
RxNorm normalized name: iopentol 300 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopentol 300 mg/ml
Trial: 7569093
Drug: Iohexol 300
RxNorm normalized name: IOHEXOL 300MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iohexol 300 mg/ml
Trial: 28505367
Drug: Health Information
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health Information Exchange (HIE) access during medication reconciliation
Trial: 26271132
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (basic medication without acupuncture intervention).
Trial: 16826094
Drug: Ceramic-on-ceramic (Ce/Ce)
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceramic-on-ceramic (Ce/Ce) implant
Trial: 16826094
Drug: Metal-on-polyethylene (PE)
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metal-on-polyethylene (PE) implant
Trial: 14616428
Drug: Diltiazem co-treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem co-treatment (30 mg or 60 mg twice daily depending on weight)
Trial: 11097144
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice pretreatment with oral scopolamine 0.5 mg
Trial: 11097144
Drug: Intravenous scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous scopolamine 0.5 mg
Trial: 11097144
Drug: Scopolamine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine administration (all routes)
Trial: 9505992
Drug: Microemulsion oral
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microemulsion oral solution
Trial: 9505992
Drug: Microemulsion soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microemulsion soft gelatin capsule
Trial: 9505992
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral solution
Trial: 9505992
Drug: Microemulsion capsule
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microemulsion capsule (200, 400, 600 mg)
Trial: 9505992
Drug: Microemulsion capsule
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microemulsion capsule (400 mg after a fat-rich meal)
Trial: 9505992
Drug: All dose
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All dose levels of microemulsion formulation
Trial: 30824635
Drug: IV golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IV golimumab (GOL) 2 mg/kg
Trial: 26597577
Drug: Ice pack
RxNorm normalized name: Ice Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice pack therapy for 24 hours after surgery
Trial: 22775354
Drug: Gabapentin-ER 600
RxNorm normalized name: gabapentin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER 600 mg evening (pm)
Trial: 22775354
Drug: Gabapentin-ER 600
RxNorm normalized name: gabapentin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER 600 mg morning (am)/600 mg pm
Trial: 22775354
Drug: Gabapentin-ER 1200
RxNorm normalized name: gabapentin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER 1200 mg pm
Trial: 22775354
Drug: Gabapentin-ER 600
RxNorm normalized name: gabapentin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER 600 mg am/1200 mg pm
Trial: 22775354
Drug: Gabapentin-ER 600
RxNorm normalized name: gabapentin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER 600 mg am/1800 mg pm
Trial: 22775354
Drug: Gabapentin-ER 1200
RxNorm normalized name: gabapentin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER 1200 mg am/1800 mg pm
Trial: 22775354
Drug: Gabapentin-ER (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin-ER (all doses)
Trial: 16352299
Drug: Tiropramide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiropramide (100 mg dose)
Trial: 16352299
Drug: Control formulation
RxNorm normalized name: nut.tx, weight loss-control formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control formulation of Tiropramide (100 mg dose)
Trial: 15257956
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rHuEPO) treatment
Trial: 11565838
Drug: IL-2 (125,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-2 (125,000 IU/kg subcutaneously daily for 12 days)
Trial: 28414254
Drug: Pressure Ulcer
RxNorm normalized name: adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pressure Ulcer Prevention Program (lifestyle-based treatment administered by healthcare professionals, largely via in-home visits and phone contacts)
Trial: 27258530
Drug: Modified Beck
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Beck Depression Inventory (BDI)-II administered to adults randomly selected from the community (n=221)
Trial: 12841925
Drug: 0.05% azelastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% azelastine eye drops, twice daily for 6 weeks
Trial: 12841925
Drug: Open-label levocabastine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label levocabastine, twice daily for 6 weeks
Trial: 10989958
Drug: Endothelin-1 (ET-1)
RxNorm normalized name: nitric oxide synthase endothelial
DrugBank: Endothelin-1 (DB12652)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelin-1 (ET-1) infusion at 20 ng/min x kg
Trial: 10989958
Drug: Endothelin-3 (ET-3)
RxNorm normalized name: nitric oxide synthase endothelial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelin-3 (ET-3) infusion
Trial: 9149659
Drug: Trans-fatty acids
RxNorm normalized name: Patty Cake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trans-fatty acids (top quintile intake, median = 6.2 g/day)
Trial: 8114055
Drug: Individual basis
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual basis administered by physician‐nurse teams (PN)
Trial: 3534198
Drug: Glycine-based oral
RxNorm normalized name: glycine Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycine-based oral rehydration solution (glycine-ORS)
Trial: 3534198
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral rehydration solution (ORS)
Trial: 24531083
Drug: NSAID-GGA group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID-GGA group (75 mg/day diclofenac sodium and 150 mg/day GGA)
Trial: 24531083
Drug: NSAID-FAM group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID-FAM group (75 mg/day diclofenac sodium and 20 mg/day famotidine)
Trial: 24327533
Drug: Bilateral coronoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral coronoid hyperplasia treatment group
Trial: 19022973
Drug: Zinc (10-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (10-mg tablets daily until discharge)
Trial: 19022973
Drug: Placebo (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (daily until discharge)
Trial: 16649407
Drug: S-adenosyl-L-methione (SAMe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosyl-L-methione (SAMe) 500mg twice daily in slow running infusion for twelve days, ongoing oral 500 mg twice daily until delivery
Trial: 16649407
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 3 x 250 mg daily
Trial: 16649407
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with both drugs (SAMe and UDCA)
Trial: 16649407
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (SAMe monotherapy)
Trial: 12794404
Drug: 7.5% hypertonic
RxNorm normalized name: SODIUM CHLORIDE 7.5 g in 100 mL ORAL LIQUID [7.5% Hypertonic Saline]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5% hypertonic saline solution (2400 mOsm/kg/H(2)O)
Trial: 6588485
Drug: Metronidazole (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (1500 mg)
Trial: 6588485
Drug: Tinidazole (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (1600 mg)
Trial: 30580680
Drug: Intensive BP
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive BP treatment (systolic BP target, <120 mm Hg)
Trial: 30580680
Drug: Standard BP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard BP treatment (systolic BP target, <140 mm Hg)
Trial: 23888450
Drug: Vaseline ointment
RxNorm normalized name: petrolatum Topical Ointment [Vaseline]
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaseline ointment (control)
Trial: 21444807
Drug: High-dose CNTF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose CNTF implant
Trial: 21444807
Drug: Low-dose CNTF
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CNTF implant
Trial: 21444807
Drug: Combined low-dose/sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined low-dose/sham group
Trial: 19802659
Drug: Fondaparinux sodium
RxNorm normalized name: Fondaparinux Sodium
DrugBank: Fondaparinux (DB00569)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fondaparinux sodium (FPX) 2.5 mg/day for 14 days
Trial: 27068249
Drug: Rate control
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rate control therapy
Trial: 14618033
Drug: Rhythm control
RxNorm normalized name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 180 mg in 1 g TOPICAL STICK [ZUSKA RHYTHM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhythm control therapy
Trial: 3553496
Drug: Captopril (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (with diuretic)
Trial: 3553496
Drug: Methyldopa (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (with diuretic)
Trial: 3553496
Drug: Propranolol (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (with diuretic)
Trial: 22142346
Drug: Triple-combination therapy
RxNorm normalized name: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-combination therapy (Olmesartan 40 mg, Amlodipine 10 mg, Hydrochlorothiazide 25 mg)
Trial: 22142346
Drug: Dual-combination (Olmesartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-combination (Olmesartan 40 mg + Amlodipine 10 mg)
Trial: 22142346
Drug: Dual-combination (Olmesartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-combination (Olmesartan 40 mg + Hydrochlorothiazide 25 mg)
Trial: 22142346
Drug: Dual-combination (Amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-combination (Amlodipine 10 mg + Hydrochlorothiazide 25 mg)
Trial: 20225470
Drug: F dentifrice
RxNorm normalized name: Stomodine F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F dentifrice (1500 microg F/g as sodium monofluorophosphate)
Trial: 12411789
Drug: ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (4 mg intravenous) with sham ReliefBand
Trial: 12411789
Drug: acustimulation (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acustimulation (saline 2 ml intravenous) with active ReliefBand
Trial: 12411789
Drug: ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (4 mg intravenous) with active ReliefBand
Trial: 7661353
Drug: CSE with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSE with 40 mg intrathecal 2% lidocaine
Trial: 7661353
Drug: CSE with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSE with 60 mg intrathecal 2% lidocaine
Trial: 7661353
Drug: CSE with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSE with 80 mg intrathecal 2% lidocaine
Trial: 2669718
Drug: 10% povidone-iodine
RxNorm normalized name: POVIDONE-IODINE 100 mg in 1 mL TOPICAL LIQUID [Saninta 10% Povidone-Iodine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% povidone-iodine pre-operative preparation for 12 hours